Pelthos Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/B Ratio-1.42
Enterprise Value Ratios
Profitability & Returns
Return on Assets (ROA)-6.46%-56.63%
Return on Capital Employed (ROCE)2.79%1.06%0.63%0.33%0.38%
Leverage & Solvency Ratios
Debt/Equity-0.81-0.20-0.15-0.30-0.07
Liquidity Ratios
Current Ratio0.340.010.010.02
Quick Ratio0.130.010.01
Efficiency Ratios
Yield & Distribution Ratios
Earnings Yield-2.06%
Buyback Yield-3.37%-1.93%